For decades the development of pharmaceuticals has been regulated by safety, efficacy and quality rules for product registration. In public health care systems, these three ‘hurdles’ are increasingly being supplemented by a fourth: pharmacoeconomics. With the current upheaval of Europe`s economy, the financial aspect is…